{"id":"W4414258520","doi":"10.51731/cjht.2025.1222","title":"Pertuzumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Reimbursement; Trastuzumab; Cancer; Breast cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002670354,0.00007069617,0.0003218826,0.0007360405,0.0001332945,0.00001457741,0.0001590576,0.00009702895,0.00003152109],"category_scores_gemma":[0.000467127,0.00005476573,0.00006994241,0.0003203045,0.0001528234,0.0000296385,0.000009069883,0.0002862337,0.000004390009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002645569,"about_ca_system_score_gemma":0.004690666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001611199,"about_ca_topic_score_gemma":0.001055218,"domain_scores_codex":[0.9992118,0.00001459258,0.0003543838,0.00007235747,0.00007756104,0.0002692791],"domain_scores_gemma":[0.9994978,0.00002260766,0.0001213542,0.0001799499,0.0001172131,0.00006109822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001102103,0.00001757424,0.01745049,0.0001761124,0.00005993765,0.0002220081,0.0001451547,0.000001156265,0.00001413921,0.01204655,0.03684089,0.933015],"study_design_scores_gemma":[0.001017833,0.0007742742,0.05428101,0.0009495644,0.00003081801,0.0009392129,0.006312283,0.00001027217,0.0001536356,0.02672792,0.9086998,0.0001033682],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2469151,0.2734538,0.0004158188,0.4651797,0.0007568096,0.0002942947,0.000005955441,0.0001304419,0.01284812],"genre_scores_gemma":[0.9963381,0.0006547762,0.0004428923,0.001945998,0.000003339913,0.000001464389,6.647907e-7,0.000004894771,0.0006079209],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9329116,"threshold_uncertainty_score":0.832104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01588028164398096,"score_gpt":0.2966004744205135,"score_spread":0.2807201927765325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}